메뉴 건너뛰기




Volumn 49, Issue 11, 2001, Pages 613-620

Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon α in the treatment of metastatic renal cell carcinoma: A pilot study

Author keywords

Cytokine therapy; GM CSF; Renal cell carcinoma

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 2; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2;

EID: 0034466551     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000159     Document Type: Article
Times cited : (24)

References (34)
  • 11
    • 0024358410 scopus 로고
    • GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma
    • (1989) Blood , vol.73 , pp. 1936
    • Kushner, B.H.1    Cheung, N.K.2
  • 15
    • 0033514050 scopus 로고    scopus 로고
    • Interferon-α and survival in metastatic renal carcinoma: Early results of a randomized controlled trial
    • (1999) Lancet , vol.353 , pp. 14
  • 25
    • 0028289244 scopus 로고
    • Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor
    • (1994) J Exp Med , vol.179 , pp. 1109
    • Sallusto, F.1    Lanzavecchia, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.